Top Medical News
Stephen Padilla, 11 hours ago
It appears that prescribing immediate antibiotics does not lessen major adverse outcomes of subsequent hospital admission or death for young people and adults with uncomplicated lower respiratory tract infection, a recent study has shown.
Roshini Claire Anthony, Yesterday

Timely and active treatment for bloodstream infections caused by carbapenemase-producing Enterobacteriaceae (CPE) is associated with lower mortality risk, according to a recent study. Moreover, only patients with a high risk of death appear to benefit from combination therapy. 

Yesterday
Temporary discontinuation of methotrexate (MTX) appears to improve the efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis (RA), according to a study.
Roshini Claire Anthony, 2 days ago

A survey conducted among inpatients in Singapore has implied a high prevalence of healthcare-associated infections (HAIs) and antimicrobial use in acute-care hospitals, according to a recent study. 

4 days ago
Meningitis, pneumonia, septicaemia and other infection-related diseases are associated with increased risks of in-hospital mortality in brain abscess in Taiwan, reports a new study.
5 days ago
Serum and cerebrospinal fluid (CSF) cytokine levels in HIV patients with cryptococcal meningitis(CM) infection are different and change during antiretroviral (ART) and antifungal therapy, a new study reports.
Roshini Claire Anthony, 7 days ago

Individuals with a Clostridium difficile (C. difficile) infection have a high risk of all-cause mortality and recurrence is common in those who survive, according to a study presented at ECCMID 2017*.

Special Reports
01 Mar 2017
At the recent Asia Pacific Alliance for the Control of Influenza (APACI) workshop in Kuala Lumpur, MIMS Doctor had the privilege of having an exclusive interview with eminent paediatric infectious disease specialist, Associate Professor Tawee Chotpitayasunondh. This article captures the highlights from our conversation with him.
Stephen Padilla, 06 Dec 2016
Dengvaxia, a recombinant, live-attenuated dengue vaccine, has the potential to bring down the number of hospitalizations by 13 to 25 percent and be cost-effective in areas of moderate-to-high dengue endemicity, according to a model comparison study.
02 Dec 2016
The Asia Pacific Alliance for the Control of Influenza (APACI) recently organized an influenza workshop in Kuala Lumpur. The workshop saw eminent speakers from seven countries presenting on topics concerning the impact of influenza, vaccination of various populations, current and upcoming treatments for influenza, policy considerations and approaches for pandemic preparedness. Read about highlights from the workshop in this newsletter. 
23 Nov 2016
At the recent Infectious Disease Symposium held on the 5th of August 2016, at Le Meridien Kuala Lumpur, two speakers spoke on the role of macrolides in the management of respiratory tract infections, as well as the importance of antibiotic stewardship in combating microbial resistance.
Dr. Joslyn Ngu, 19 Aug 2016

The rise of anti-malarial resistant Plasmodium falciparum in areas where malaria is endemic, such as Southeast Asia, calls for the safe and right use of current antimalarials.

30 Jul 2016
Antimicrobial resistance is an increasingly serious threat to global public health. To address this, Associate Professor de Castro recently sat down with MIMS Doctor to give her views on the judicious use of antimicrobial agents.
Roshini Claire Anthony, 05 Jul 2016

Renal transplant recipients have a high incidence of hospitalization due to pyelonephritis, according to a Danish population-based cohort study.

Conference Reports
Pearl Toh, 09 Mar 2017
Pearl Toh finds out from Professor Anna Lok, director of clinical hepatology at the University of Michigan in Ann Arbor, Michigan, US, on integrating guidelines, research data, and clinical setting in decision making for management of hepatitis B during the recent Asian Pacific Association for the Study of the Liver Annual Meeting held in Shanghai, China.

Pearl Toh, 08 Mar 2017
Add-on of pegylated interferon (pegIFN) to nucleos(t)ide analogues (NA) therapy may be a better strategy than a switch from NA to pegIFN in patients with chronic hepatitis B (CHB) who are on long-term NA therapy, according to data from an interim analysis of the SWAP* study presented at the recent Asian Pacific Association for the Study of the Liver Annual Meeting (APASL 2017) held in Shanghai, China.
Pearl Toh, 24 Feb 2017
The goal of treatment for portal hypertension varies depending on the different stages and substages of cirrhosis, and hence, pharmacological therapies for managing portal hypertension should be considered in the context of other complications of cirrhosis, according to a presentation at the recent APASL 2017 held in Shanghai, China recently.
24 Feb 2017
Slideshow: Highlights from the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Shanghai, China, February 15 - 19.
Roshini Claire Anthony, 23 Feb 2017

The use of statins is associated with a lower risk of pyogenic liver abscess, according to a Taiwan population-based case-control study. 

Roshini Claire Anthony, 22 Feb 2017

Individuals with hepatitis C virus (HCV) infection who achieve a sustained virological response (SVR) have improved liver stiffness and a lower risk of hepatocellular carcinoma (HCC), according to a presentation at the Asian Pacific Association for the Study of the Liver annual meeting (APASL 2017) in Shanghai, China.

Jairia Dela Cruz, 22 Feb 2017
An 8- to 16-week treatment regimen of elbasvir/grazoprevir plus sofosbuvir with or without ribavirin appears to be highly effective and well tolerated in both treatment-naïve and treatment-experienced cirrhotic patients with hepatitis C virus (HCV) genotype 3 (GT3) infection, according to the results of the C-ISLE study presented at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL) held in Shanghai, China.